Literature DB >> 11222477

Recombinant soluble p-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine.

J G Bienvenu1, J F Tanguay, J F Théorêt, A Kumar, R G Schaub, Y Merhi.   

Abstract

BACKGROUND: P-selectin mediates leukocyte recruitment to activated platelets and endothelium through its high-affinity receptor P-selectin glycoprotein ligand-1 (PSGL-1). Platelet and leukocyte activation and binding have been reported after coronary angioplasty and were correlated with restenosis. We investigated the effect of a recombinant soluble PSGL-1 (rPSGL-Ig) on the adhesion of platelets and neutrophils and the development of restenosis after double arterial injury. METHODS AND
RESULTS: Four weeks after angioplasty of both carotid arteries in pigs, a second angioplasty was performed at the same sites, 15 minutes after a single administration of vehicle or rPSGL-1 (1 mg/kg IV). Animals were euthanized 1 hour, 4 hours, 1 week, or 4 weeks later. Adhesion of autologous (51)Cr-platelets and (111)In-neutrophils was quantified and histological/morphometric analyses were performed. Although rPSGL-Ig did not affect adherence of these cells 1 hour after injury, it significantly reduced the adhesion of platelets (50% at 4 hours and 85% at 1 week) and neutrophils (50% at 4 hours and 78% at 1 week) to deeply injured arteries. At 4 weeks, the residual lumen was 63% larger in rPSGL-Ig-treated arteries as compared with control arteries (6.1+/-0.6 versus 3.8+/-0.1 mm(2); P:<0.002). The neointimal area was slightly reduced (0.5 in rPSGL-Ig versus 0.7 mm(2) in control). The ratio of the external elastic lamina of injured to uninjured reference segments was >1 in treated arteries and <1 in control arteries.
CONCLUSIONS: P-selectin antagonism with rPSGL-Ig inhibits early platelet/leukocyte adhesion on injured arteries and reduces restenosis through a positive impact on vascular remodeling. Hence, rPSGL-Ig may have potential in the prevention of restenosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222477     DOI: 10.1161/01.cir.103.8.1128

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

1.  Recombinant P-selectin glycoprotein-ligand-1 delays thrombin-induced platelet aggregation: a new role for P-selectin in early aggregation.

Authors:  Jean-François Théorêt; Wissam Chahrour; Daniel Yacoub; Yahye Merhi
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

2.  Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo.

Authors:  N M Valenzuela; L Hong; X-Da Shen; F Gao; S H Young; E Rozengurt; J W Kupiec-Weglinski; M C Fishbein; E F Reed
Journal:  Am J Transplant       Date:  2012-12-27       Impact factor: 8.086

Review 3.  Inflammation and vascular injury: basic discovery to drug development.

Authors:  Daniel I Simon
Journal:  Circ J       Date:  2012-07-30       Impact factor: 2.993

Review 4.  Cardiovascular devices and platelet interactions: understanding the role of injury, flow, and cellular responses.

Authors:  Jesse W Rowley; Aloke V Finn; Patricia A French; Lisa K Jennings; Danny Bluestein; Peter L Gross; Jane E Freedman; Steven R Steinhubl; Guy A Zimmerman; Richard C Becker; Harold L Dauerman; Susan S Smyth
Journal:  Circ Cardiovasc Interv       Date:  2012-04       Impact factor: 6.546

5.  Serum concentrations of soluble P-selectin glycoprotein ligand-1 are increased in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis.

Authors:  K Yanaba; K Takehara; S Sato
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

6.  The value of leukocyte adhesion molecules in patients after ischemic stroke.

Authors:  Nai-Wen Tsai; Wen-Neng Chang; Chen-Fu Shaw; Chung-Ren Jan; Chi-Ren Huang; Shang-Der Chen; Yao-Chung Chuang; Lian-Hui Lee; Cheng-Hsien Lu
Journal:  J Neurol       Date:  2009-04-08       Impact factor: 4.849

7.  Association of the single-nucleotide polymorphism and haplotype of the P-selectin gene with ischemic stroke.

Authors:  Ye-Sheng Wei; Yan Lan; Rui-Ya Huang; Yun-Guang Liu; Ren-Guang Tang; Qun-Qing Xu; Lan-Qing Meng
Journal:  J Thromb Thrombolysis       Date:  2007-11-24       Impact factor: 2.300

8.  Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Kelly A Volcik; Christie M Ballantyne; Josef Coresh; Aaron R Folsom; Eric Boerwinkle
Journal:  Atherosclerosis       Date:  2007-04-08       Impact factor: 5.162

9.  Evolutionary conservation of P-selectin glycoprotein ligand-1 primary structure and function.

Authors:  Bénédicte Baïsse; Frédérique Galisson; Sylvain Giraud; Marc Schapira; Olivier Spertini
Journal:  BMC Evol Biol       Date:  2007-09-14       Impact factor: 3.260

10.  Core2 1-6-N-glucosaminyltransferase-I deficiency protects injured arteries from neointima formation in ApoE-deficient mice.

Authors:  Huan Wang; Weiyu Zhang; Rong Tang; Robert P Hebbel; M Anna Kowalska; Chunxiang Zhang; Jamey D Marth; Minoru Fukuda; Chuhong Zhu; Yuqing Huo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-04-16       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.